arsenic trioxide has been researched along with Chondrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, W; Jiao, G; Ren, C; Ren, T; Yang, K | 1 |
| Bao, X; Guo, W; Huang, Y; Liu, K; Ren, T; Wang, S; Zhang, F; Zheng, B | 1 |
2 other study(ies) available for arsenic trioxide and Chondrosarcoma
| Article | Year |
|---|---|
Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Bone Neoplasms; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chondrosarcoma; G2 Phase Cell Cycle Checkpoints; Humans; Oxides; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chondrosarcoma; DNA Demethylation; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Oxides; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2016 |